ClinicalTrials.govpublic full text
Korean Post-marketing Surveillance for Xeljanz XR
active moderate to severe rheumatoid arthritis, active ankylosing spondylitis, active psoriatic arthritis, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979928
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.